Benchmark Upgrades Meta to Buy, $820 Price Target

Analyst: Mark Zgutowicz 1 min read Reproduced verbatim Published as The Benchmark Company, now part of StoneX
Rating
Buy
from Hold
Target
$820
Outcome
Missed
within 12 months

StoneX’s latest target on Meta is now $890 (Jul 31, 2025); the median of 33 firms is $850. StoneX has reached 67% of its year-old targets (33 scored).

StoneX and Meta logos

What the analyst said

Benchmark analyst Mark Zgutowicz upgraded Meta Platforms Inc. (NASDAQ: META) from Hold to Buy with a price target of $820.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

META trades at $596. The 33 analysts who set a target in the last 3 months range from $650 to $1,000, with a median of $850. This $820 target is 4% below the median.

Since the note META has moved −12% (from $676). The 12-month window closed on January 30, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note META closed at $717, 13% below the $820 target, but it moved the way the analyst expected.

Firm track recordStoneX: 67% of its 33 targets at least a year old were reached within 12 months (#27 of 29 firms); on Meta, 1 of 4. Accuracy ranking →

Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.